Achieving optimal management in a patient with T2D and severe hyperglycemia Prof Merlin Thomas Prof Merlin Thomas Related contents J.M Co, Prof Cooper What do you think of the safety profile of the DPP4-inhibitors? 1.1.2023 J.M Co, Prof Cooper Is Trajenta (linagliptin) contraindicated in renal failure? 1.1.2023 J.M Co, Prof Cooper Is DPP4i suitable for admitted patients? 1.1.2023 Home Expert Videos Expert Insights from Professor Merlin Thomas on Optimal T2DM